{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:09:25Z","timestamp":1793880565041,"version":"4.7.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ygyno.2022.12.008","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T17:41:26Z","timestamp":1674236486000},"page":"133-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Mismatch-repair deficiency, microsatellite instability, and lynch syndrome in ovarian cancer: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"170","author":[{"given":"Cristina","family":"Mitric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lusine","family":"Abrahamyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoun Rachel","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Pechlivanoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin K.W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian T.","family":"Gien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2022.12.008_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2009.01230.x","article-title":"Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications","volume":"76","author":"Lynch","year":"2009","journal-title":"Clin. Genet."},{"issue":"1","key":"10.1016\/j.ygyno.2022.12.008_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"22","key":"10.1016\/j.ygyno.2022.12.008_bb0015","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA."},{"issue":"22","key":"10.1016\/j.ygyno.2022.12.008_bb0020","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1002\/cncr.33144","article-title":"Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer","volume":"126","author":"Kim","year":"2020","journal-title":"Cancer."},{"key":"10.1016\/j.ygyno.2022.12.008_bb0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejca.2015.12.005","article-title":"Ovarian cancer in Lynch syndrome; a systematic review","volume":"55","author":"Helder-Woolderink","year":"2016","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2022.12.008_bb0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.6004\/jnccn.2021.0007","article-title":"Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"19","author":"Armstrong","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"1","key":"10.1016\/j.ygyno.2022.12.008_bb0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst. Rev."},{"key":"10.1016\/j.ygyno.2022.12.008_bb0040","author":"Innovation"},{"issue":"22","key":"10.1016\/j.ygyno.2022.12.008_bb0045","first-page":"5248","article-title":"A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer","volume":"58","author":"Boland","year":"1998","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2022.12.008_bb0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume":"13","author":"Munn","year":"2015","journal-title":"Int. J. Evid. Based Healthc."},{"key":"10.1016\/j.ygyno.2022.12.008_bb0055","author":"Team"},{"key":"10.1016\/j.ygyno.2022.12.008_bb0060","author":"Training"},{"key":"10.1016\/j.ygyno.2022.12.008_bb0065","series-title":"Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors","author":"Gras","year":"2001"},{"issue":"11","key":"10.1016\/j.ygyno.2022.12.008_bb0070","first-page":"4371","article-title":"Application of the National Cancer Institute international criteria for determination of microsatellite instability in ovarian cancer","volume":"61","author":"Sood","year":"2001","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.ygyno.2022.12.008_bb0075","first-page":"1387","article-title":"Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium","volume":"9","author":"Shannon","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.ygyno.2022.12.008_bb0080","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.humpath.2003.12.009","article-title":"Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma","volume":"35","author":"Cai","year":"2004","journal-title":"Hum. Pathol."},{"issue":"11","key":"10.1016\/j.ygyno.2022.12.008_bb0085","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.humpath.2004.07.019","article-title":"Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas","volume":"35","author":"Catasus","year":"2004","journal-title":"Hum. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2022.12.008_bb0090","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ijc.20455","article-title":"Different types of microsatellite instability in ovarian carcinoma","volume":"112","author":"Singer","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"36","key":"10.1016\/j.ygyno.2022.12.008_bb0095","doi-asserted-by":"crossref","first-page":"9344","DOI":"10.1200\/JCO.2005.03.5915","article-title":"Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?","volume":"23","author":"Soliman","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2022.12.008_bb0100","first-page":"2785","article-title":"Microsatellite status and immunohistochemical features of ovarian clear-cell carcinoma","volume":"25","author":"Ueda","year":"2005","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.ygyno.2022.12.008_bb0105","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1525-1438.2007.00875.x","article-title":"Ovarian cancer at young age: the contribution of mismatch-repair defects in a population-based series of epithelial ovarian cancer before age 40","volume":"17","author":"Domanska","year":"2007","journal-title":"Int. J. Gynecol. Cancer."},{"issue":"3","key":"10.1016\/j.ygyno.2022.12.008_bb0110","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ygyno.2011.02.010","article-title":"Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors","volume":"121","author":"Ketabi","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.12.008_bb0115","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ygyno.2005.10.029","article-title":"The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer","volume":"101","author":"Malander","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2022.12.008_bb0120","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/PAS.0b013e31816380c4","article-title":"Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger","volume":"32","author":"Jensen","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.12.008_bb0125","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ygyno.2021.07.001","article-title":"Lynch syndrome-associated epithelial ovarian cancer and its immunological profile","volume":"162","author":"Rasmussen","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.12.008_bb0130","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3349\/ymj.2008.49.2.272","article-title":"Clinical significance of microsatellite instability in sporadic epithelial ovarian tumors","volume":"49","author":"Yoon","year":"2008","journal-title":"Yonsei Med. J."},{"issue":"4","key":"10.1016\/j.ygyno.2022.12.008_bb0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3802\/jgo.2011.22.4.233","article-title":"Synchronous gynecologic malignancy and preliminary results of Lynch syndrome","volume":"22","author":"Kim","year":"2011","journal-title":"J. Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.12.008_bb0140","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/cncr.24012","article-title":"Consideration of hereditary nonpolyposis colorectal cancer in BRCA mutation-negative familial ovarian cancers","volume":"115","author":"South","year":"2009","journal-title":"Cancer."},{"issue":"3","key":"10.1016\/j.ygyno.2022.12.008_bb0145","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2018.29.e29","article-title":"Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer","volume":"29","author":"Takeda","year":"2018","journal-title":"J. Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.12.008_bb0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ygyno.2015.12.017","article-title":"Genetic characterization of early onset ovarian carcinoma","volume":"140","author":"Bernards","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2022.12.008_bb0155","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1200\/JCO.18.00283","article-title":"Microsatellite instability is associated with the presence of lynch syndrome pan-cancer","volume":"37","author":"Latham","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2022.12.008_bb0160","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.12.008_bb0165","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ygyno.2009.11.021","article-title":"Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening","volume":"116","author":"Walsh","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.12.008_bb0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/PAS.0b013e31823bc434","article-title":"Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability","volume":"36","author":"Aysal","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"issue":"6","key":"10.1016\/j.ygyno.2022.12.008_bb0175","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/PGP.0b013e31824fe2aa","article-title":"Prevalence of loss of expression of DNA mismatch repair proteins in primary epithelial ovarian tumors","volume":"31","author":"Lu","year":"2012","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"5","key":"10.1016\/j.ygyno.2022.12.008_bb0180","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00428-019-02528-6","article-title":"Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK\/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma","volume":"474","author":"Schmoeckel","year":"2019","journal-title":"Virchows Arch."},{"issue":"3","key":"10.1016\/j.ygyno.2022.12.008_bb0185","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10689-017-9973-1","article-title":"Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens","volume":"16","author":"Akbari","year":"2017","journal-title":"Familial Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2022.12.008_bb0190","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/gtmb.2013.0393","article-title":"Association between IHC and MSI testing to identify mismatch repair-deficient patients with ovarian cancer","volume":"18","author":"Lee","year":"2014","journal-title":"Genetic Test. Mol. Biomark."},{"issue":"5","key":"10.1016\/j.ygyno.2022.12.008_bb0195","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/PAS.0000000000001432","article-title":"Mismatch repair deficiency in ovarian carcinoma: frequency, causes, and consequences","volume":"44","author":"Leskela","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"issue":"10","key":"10.1016\/j.ygyno.2022.12.008_bb0200","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/bjc.2012.452","article-title":"Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer","volume":"107","author":"Pal","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.ygyno.2022.12.008_bb0205","first-page":"2596","article-title":"Distinct molecular profiles in Lynch syndrome-associated and sporadic ovarian carcinomas","volume":"133","author":"Niskakoski","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2022.12.008_bb0210","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0000000000000298","article-title":"The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy","volume":"38","author":"Chui","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"issue":"17","key":"10.1016\/j.ygyno.2022.12.008_bb0215","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1093\/hmg\/ddu172","article-title":"The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population","volume":"23","author":"Song","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ygyno.2022.12.008_bb0220","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ygyno.2014.07.100","article-title":"Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary","volume":"135","author":"Vierkoetter","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2022.12.008_bb0225","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamaoncol.2015.2690","article-title":"Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment","volume":"1","author":"Desmond","year":"2015","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.12.008_bb0230","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/IGC.0000000000000377","article-title":"Clinicopathologic analysis with immunohistochemistry for DNA mismatch repair protein expression in synchronous primary endometrial and ovarian cancers","volume":"25","author":"Kobayashi","year":"2015","journal-title":"Int. J. Gynecol. Cancer."},{"issue":"1","key":"10.1016\/j.ygyno.2022.12.008_bb0235","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ygyno.2015.01.537","article-title":"Hereditary predisposition to ovarian cancer, looking beyond BRCA1\/BRCA2","volume":"137","author":"Minion","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2022.12.008_bb0240","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/PAS.0000000000000602","article-title":"Mismatch repair protein expression in clear cell carcinoma of the ovary: incidence and morphologic associations in 109 cases","volume":"40","author":"Bennett","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.12.008_bb0245","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/PAS.0000000000001165","article-title":"Incidence of mismatch repair protein deficiency and associated clinicopathologic features in a cohort of 104 ovarian endometrioid carcinomas","volume":"43","author":"Bennett","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.12.008_bb0250","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/his.12934","article-title":"Significant frequency of MSH2\/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas","volume":"69","author":"Rambau","year":"2016","journal-title":"Histopathology."},{"issue":"8","key":"10.1016\/j.ygyno.2022.12.008_bb0255","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/gim.2015.166","article-title":"Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing","volume":"18","author":"Susswein","year":"2016","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2022.12.008_bb0260","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/PGP.0000000000000384","article-title":"Microcystic, elongated, and fragmented pattern invasion in ovarian endometrioid carcinoma: immunohistochemical profile and prognostic implications","volume":"37","author":"Goldberg","year":"2018","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.12.008_bb0265","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ygyno.2018.09.030","article-title":"Germline pathogenic variants identified in women with ovarian tumors","volume":"151","author":"Carter","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"68","key":"10.1016\/j.ygyno.2022.12.008_bb0270","doi-asserted-by":"crossref","first-page":"112258","DOI":"10.18632\/oncotarget.22733","article-title":"Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer","volume":"8","author":"Hirasawa","year":"2017","journal-title":"Oncotarget."},{"issue":"64","key":"10.1016\/j.ygyno.2022.12.008_bb0275","doi-asserted-by":"crossref","first-page":"108020","DOI":"10.18632\/oncotarget.22445","article-title":"Sequencing of Lynch syndrome tumors reveals the importance of epigenetic alterations","volume":"8","author":"Porkka","year":"2017","journal-title":"Oncotarget."},{"issue":"2","key":"10.1016\/j.ygyno.2022.12.008_bb0280","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/his.13040","article-title":"Long-term survival of patients with mismatch repair protein-deficient, high-stage ovarian clear cell carcinoma","volume":"70","author":"Stewart","year":"2017","journal-title":"Histopathology."},{"issue":"8","key":"10.1016\/j.ygyno.2022.12.008_bb0285","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/jjco\/hyy081","article-title":"Prevalence and molecular characteristics of defective mismatch repair epithelial ovarian cancer in a Japanese hospital-based population","volume":"48","author":"Tajima","year":"2018","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2022.12.008_bb0290","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/CEJ.0000000000000711","article-title":"Strategies for Lynch syndrome identification in selected and unselected gynecological cancers","volume":"31","author":"Carnevali","year":"2021","journal-title":"Eur. J. Cancer Prevent."},{"key":"10.1016\/j.ygyno.2022.12.008_bb0295","article-title":"Inherited cancer syndromes in 220 Italian ovarian cancer patients","volume":"237","author":"Di Lauro","year":"2019","journal-title":"Cancer Gene Ther."},{"issue":"10","key":"10.1016\/j.ygyno.2022.12.008_bb0300","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/jmedgenet-2020-107270","article-title":"Assessment of mismatch repair deficiency in ovarian cancer","volume":"58","author":"Crosbie","year":"2021","journal-title":"J. Med. Genet."},{"issue":"3","key":"10.1016\/j.ygyno.2022.12.008_bb0305","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/cam4.3688","article-title":"Prevalence of Lynch syndrome in women with mismatch repair-deficient ovarian cancer","volume":"10","author":"Hodan","year":"2021","journal-title":"Cancer Med."},{"issue":"2","key":"10.1016\/j.ygyno.2022.12.008_bb0310","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/PGP.0000000000000682","article-title":"Diffuse intratumoral stromal inflammation in ovarian clear cell carcinoma is associated with loss of mismatch repair protein and high PD-L1 expression","volume":"40","author":"Lin","year":"2021","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"5","key":"10.1016\/j.ygyno.2022.12.008_bb0315","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4274\/haseki.galenos.2020.6125","article-title":"Microsatellite instability in ovarian invasive and borderline epithelial tumors and comparison with prognostic parameters","volume":"58","author":"Turkel","year":"2020","journal-title":"Haseki Tip Bulteni."},{"issue":"1","key":"10.1016\/j.ygyno.2022.12.008_bb0320","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13000-021-01071-w","article-title":"Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma","volume":"16","author":"Ge","year":"2021","journal-title":"Diagn. Pathol."},{"issue":"11","key":"10.1016\/j.ygyno.2022.12.008_bb0325","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1097\/PAS.0000000000001798","article-title":"Accurate distinction of ovarian clear cell from endometrioid carcinoma requires integration of phenotype, immunohistochemical predictions, and genotype: implications for lynch syndrome screening","volume":"45","author":"Rodriguez","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"issue":"7","key":"10.1016\/j.ygyno.2022.12.008_bb0330","doi-asserted-by":"crossref","first-page":"314","DOI":"10.12788\/jcso.0181","article-title":"Hereditary cancer testing in patients with ovarian cancer using a 25-gene panel","volume":"14","author":"Langer","year":"2016","journal-title":"J. Commun. Support. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2022.12.008_bb0335","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/ijc.25835","article-title":"Frequency of mismatch repair deficiency in ovarian cancer: a systematic review This article is a US Government work and, as such, is in the public domain of the United States of America","volume":"129","author":"Murphy","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2022.12.008_bb0340","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.34165","article-title":"The prevalence of mismatch repair deficiency in ovarian cancer: A systematic review and meta-analysis","volume":"151","author":"Atwal","year":"2022","journal-title":"Int. J. Cancer"},{"issue":"21","key":"10.1016\/j.ygyno.2022.12.008_bb0345","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-08-1387","article-title":"Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology","volume":"14","author":"Pal","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2022.12.008_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study","volume":"38","author":"Marabelle","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.12.008_bb0355","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10689-020-00226-w","article-title":"Comparison of universal screening in major lynch-associated tumors: a systematic review of literature","volume":"21","author":"Kunnackal John","year":"2022","journal-title":"Familial Cancer"},{"key":"10.1016\/j.ygyno.2022.12.008_bb0360","series-title":"NCCN Guidelines Version 1.2021 Lynch Syndrome","author":"Network NNCC","year":"2021"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822019953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822019953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:49:43Z","timestamp":1715820583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825822019953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":72,"alternative-id":["S0090825822019953"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.12.008","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mismatch-repair deficiency, microsatellite instability, and lynch syndrome in ovarian cancer: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}